Colorectal Cancer Metastatic: Disease Bioinformatics
Colorectal cancer, commonly referred to as colon cancer, originates in the colon (large intestine) or rectum, typically as adenomatous polyps. It is unknown what causes cancer yet familial adenomatous polposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) are thought to increase risk of developing colon cancer. Additionally, increasing age, inflammatory intestinal conditions, nationality, low fiber and high fat diet, diabetes, smoking, alcohol, obesity, and a sedentary lifestyle can contribute to its onset. Treatments for colon cancer include surgery, chemotherapy, radiation therapy, and targeted drug therapy. Metastatic colon cancer occurs when the cancer has spread, or metastasized, to distant locations of the body, most commonly the liver, lungs and bones.
Colorectal Cancer Metastatic Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Colorectal Cancer Metastatic below!
For more information on how to use Laverne, please read the How to Guide.
We have 1568 products for the study of Colorectal Cancer Metastatic that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.